Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Early Promise Of NextCure’s Novel IO Candidate Continues To Fade
Jul 13 2020
•
By
Mandy Jackson
Two PD-1/L1 refractory lung cancer patients remain the only reported responders to NC318 • Source: Shutterstock
More from Clinical Trials
More from R&D